Cabozantinib 40mg price in India, uses, and side effects

Cabozantinib 40mg is used to treat kidney, thyroid, and liver cancer. It works by slowing or stopping the growth of cancer cells.

Cabozantinib comes in the form of a tablet, which should be taken on an empty stomach. It is important not to crush, chew, or break the tablet; instead, swallow it whole. It is important to take cabozantinib as prescribed by your doctor to maximize its effectiveness and minimize the risk of side effects.

Cabozantinib 40mg is a medicine used to treat certain types of cancer. It works by blocking signals that allow cancer cells to grow and multiply, as well as blocking the growth of new blood vessels in the area of the tumor.

Take this medicine one hour before or two hours after meals, as directed by your doctor. Your doctor will decide the dose and duration of cabozantinib based on your medical condition and response to the treatment. Taking this medicine exactly as prescribed by your doctor is important. If you experience any side effects or have any questions, please talk to your doctor.

To avoid missing a dose, try to adhere to your regular dosing schedule. Additionally, make sure to store this medicine away from heat or light, as these can reduce the effectiveness of the medication. By following these simple instructions, you can ensure that you are receiving the maximum benefit from this medication.

Benefits of Cabozantinib Tablet

Cabozantinib 40mg tab is an effective medication used to treat a variety of cancers, including kidney, liver, and thyroid cancer. This medication works by preventing cancer cells from growing and multiplying, and it also helps to keep new blood vessels from growing in the vicinity of the tumor. By preventing cancer cells from multiplying, cabozantinib helps to slow down the progression of certain types of cancer.

It is also used to treat advanced-stage cancers. Patients taking cabozantinib should be aware of possible side effects, including nausea, vomiting, diarrhea, and hair loss. In addition, regular blood tests and scans may be necessary to monitor the effectiveness of the treatment. Cabozantinib is an effective medication for treating a variety of cancers and can help to slow down the progression of the disease.

Cabozantinib mechanism of action

Cabozantinib is a small-molecule kinase inhibitor that works by blocking the activity of several tyrosine kinases, including c-MET, VEGFR, AXL, and others. By doing this, cabozantinib is able to reduce the tumor’s ability to grow new blood vessels, its motility, and its invasiveness.

This mechanism of action is pivotal in the treatment of cancer, as it prevents the tumor from growing and spreading, ultimately leading to better patient outcomes.

Cabozantinib s malate

Cabozantinib-s-malate is approved to treat:

• Cabometyx, a brand of cabozantinib-s-malate, is a medication approved for treating thyroid cancer that has spread to other parts of the body. It is prescribed to adults and children aged 12 and older whose cancer has progressed after receiving VEGF receptor-targeted therapy and who are unable to receive radioactive iodine.
• Cabometyx has been clinically proven to be effective in combating this type of cancer and may help to reduce the spread of the disease to other parts of the body. Patients being treated with Cabometyx should discuss any potential side effects with their doctor before beginning treatment.
• Hepatocellular cancer is a type of liver cancer that is often treated with the drug sorafenib. When this treatment fails, Cabometyx, a brand of cabozantinib-s-malate, is approved for use in these patients.
• Cabometyx has been studied in several clinical trials as a second-line therapy for hepatocellular cancer, and its efficacy has been proven. Patients treated with Cabometyx have experienced significant improvement in overall survival and progression-free survival compared to those who received sorafenib. In addition, Cabometyx has been found to be well-tolerated, with a favorable safety profile. This makes it an ideal treatment option for patients with hepatocellular cancer who have previously received sorafenib.
• Medullary thyroid cancer, an uncommon form of thyroid cancer, is a serious condition that can progress and spread to other parts of the body. In cases where the cancer has spread, the US Food and Drug Administration has approved the Cometriq brand of cabozantinib-s-malate for use.
• This drug is designed to target the cancer cells and reduce their growth, helping to slow the progression of the cancer. Clinical trials have shown that cabozantinib-s-malate is an effective treatment for medullary thyroid cancer that has spread, and it can help lead to better outcomes for those affected by this serious condition.
• Renal cell carcinoma is a type of kidney cancer that has progressed, and Cabozantinib-s-malate, which is marketed under the brand Cabometyx, is approved for use either in conjunction with or in place of nivolumab as the initial therapy. This medication can be used to treat the condition, and has been found to be a safe and effective form of treatment.
• Cabometyx has been studied in numerous clinical trials and has been found to be well-tolerated and provide significant improvements in patient outcomes. Additionally, Cabometyx has been found to be cost-effective, making it a viable option for many patients. As with any medication, there may be side effects associated with Cabometyx, so it is important to discuss any concerns with a doctor before taking the medication.

Cabozantinib-s-malate is also being researched for the treatment of other types of cancer.

References:

1. Ipsen Pharma, Electronic Medicines Compendium (EMC), [Revised on Sep 2021] [Accessed on 25th Dec 2021], https://www.medicines.org.uk/emc/files/pil.4331.pdf
2. Exelixis, Inc., [Revised on Oct 2020] [Accessed on 25th Dec 2021], https://www.cometriq.com/downloads/Cometriq_Full_Prescribing_Information.pdf